Дексапос

Quick links to important sections

Дексапос

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Дексапос

Quick Facts

Property Description
Active Ingredient Dexamethasone
Pharmacological Class Glucocorticoid (Corticosteroid)
Origin Synthetic (Fluorinated adrenocortical steroid)
Forms Tablet, Solution (Injectable, Ophthalmic), Elixir
Common Role Potent Anti-inflammatory and Immunosuppressant

Identity and Classification: What is Дексапос?

Дексапос is a medication containing the active ingredient Dexamethasone, which is categorized as a powerful, synthetic Glucocorticoid—a type of Corticosteroid. Dexamethasone is an adrenocortical steroid analog primarily used for its ability to reduce inflammation and suppress immune responses. This means the medicine is structured to manage inflammatory issues throughout the body.

As a synthetic compound characterized by its high potency and relatively long duration of action, Dexamethasone differs from less potent, shorter-acting corticosteroids. Because of this strength and the complexity of its effects, Дексапос is designated as a prescription-only (Rx) product, suitable for conditions requiring intensive anti-inflammatory intervention.

Pharmaceutical Forms and General Purpose

The medication is available in various dosage forms, including oral tablets, liquid solutions for both oral ingestion and parenteral (injection) administration, and specialized ophthalmic agents (eye drops). The versatility of these forms allows for localized or systemic delivery based on therapeutic requirements, such as controlling acute allergic flare-ups.

The overarching purpose of Дексапос is to function as a strong anti-inflammatory agent and immunosuppressive agent. This fundamental role involves controlling severe inflammation and unwanted immune system activity. The availability across multiple forms, including sterile solutions and tablets, allows for therapeutic adjustment based on the site and severity of the inflammation.

What side effects are possible with Дексапос?

Possible Side Effects and Safety Information: Dexamethasone Phosphate Eye Drops

As with any medication, dexamethasone phosphate eye drops (such as Дексапос) can cause side effects. These are typically localized to the eye and are often temporary. It is important to follow the prescribed dosage and inform your healthcare provider if any side effects are persistent or concerning.


Common and Less Common Side Effects

Classification Symptom
Common (Often Temporary) Blurred vision (shortly after application), stinging, burning, or irritation in the eye, eye discomfort.
Less Common Increased sensitivity to light (photophobia), eye dryness or watering, feeling like something is in the eye.

Serious Side Effects and Safety Concerns

Prolonged use of corticosteroid eye drops, typically beyond the duration prescribed by a doctor, can increase the risk of serious ocular complications. Contact your doctor immediately if you experience:

  • Vision changes: Worsening blurred vision, tunnel vision, or seeing halos around lights, as these can be signs of glaucoma (increased pressure inside the eye) or cataracts (clouding of the lens).
  • Eye pain or infection: Sudden or severe eye pain, persistent redness, excessive discharge, or swelling of the eyelids, which may indicate a new or worsening eye infection.
  • Allergic reaction: Symptoms such as hives, rash, swelling of the face, lips, tongue, or throat, or difficulty breathing require immediate medical attention.

Safety Precautions

  • Dexamethasone eye drops can mask signs of an active eye infection, especially viral infections like ocular herpes simplex, which is a contraindication for use. Do not use this product if you have an active, untreated eye infection.
  • If you wear soft contact lenses, they must be removed before applying the drops. Wait at least 15 minutes after administration before reinserting them, as the preservative (often benzalkonium chloride) can be absorbed by the lenses.

Overdose and Emergency Response

Regulatory documentation on Дексапос (Dexamethasone) overdose indicates that acute toxicity is generally low. However, high-dose or prolonged exposure is consistently associated with a specific profile of severe physiological manifestations. Documented clinical presentations include severe electrolyte and fluid disturbances, such as hypokalemic alkalosis and hypertension, alongside endocrine effects leading to symptoms of a Cushingoid state.

The most serious risks require immediate medical attention, particularly heart rhythm disturbances resulting from metabolic changes, the potential for severe psychiatric problems (including confusion or suicidal ideation), and the reported risk of a pheochromocytoma crisis in susceptible patients. Emergency response guidelines mandate that individuals must seek immediate medical attention and contact a Poison Control center for suspected overdose, especially if there is difficulty breathing or collapse.

Management procedures are strictly symptomatic and supportive, as no specific antidote is known, requiring close monitoring of vital signs and fluid/electrolyte balance in a clinical setting. Regulatory labels note that elderly patients require close clinical supervision due to an increased risk of serious consequences from adverse reactions.

Therapeutic Uses of Дексапос

What Дексапос Treats: Main Uses and Benefits

Quick Fact: Symptomatic Support Summary

Category Typical Context of Use Primary Symptom Benefit
Inflammatory/Autoimmune Acute, severe flare-ups Easing pronounced swelling and pain
Critical/Respiratory Hospitalized patient support Support toward symptom stability during crisis
Palliative/Supportive Managing edema or oncology discomfort Supports the easing of the overall symptom load

The medication is commonly used to help manage severe symptomatic discomfort that is linked to heightened physiological activity. It is applied across domains where additional symptomatic support is needed, primarily addressing groups of symptoms that may appear suddenly or intensify over time.

This medication is generally relevant for easing symptoms related to inflammatory or irritative states in conditions such as acute episodes of rheumatoid arthritis, gout, systemic lupus erythematosus, severe allergic reactions, acute asthma attacks, and may assist in managing the symptomatic burden of conditions like cerebral edema and certain oncological disorders.

Дексапос is applied in clinical settings that involve acute or unstable symptom patterns, and may contribute to comfort during periods of heightened symptoms.

“It provides supportive relief when symptoms interfere with routine activities, and may assist with maintaining functional stability.”

Eligibility and Restrictions for Use

The eligibility for using Dexamethasone, the active ingredient in Дексапос, is strictly defined by regulatory authorities based on population group and pre-existing conditions.

Contraindicated Populations

Use is contraindicated and formally prohibited for patients with systemic fungal infections, known hypersensitivity to any component of the formulation, and those receiving live or live attenuated vaccines.

Age and Physiological Restrictions

Population Regulatory Status
Adults Eligible for use under standard labeled conditions.
Children Safety and efficacy are not established in all pediatric populations. Use is restricted due to risk of growth suppression.
Older Adults Requires caution due to a higher prevalence of age-related conditions (e.g., osteoporosis, renal/hepatic issues).
Pregnant Women Restricted use; permitted only when the benefit justifies the potential risk to the fetus.
Breastfeeding Women Not recommended; mothers on pharmacologic doses should generally avoid breastfeeding.

Condition-Based Eligibility Limitations

Conditional use and close monitoring are required for patients with: renal or hepatic impairment, certain active infections (e.g., ocular herpes simplex, latent amebiasis), congestive heart failure, hypertension, peptic ulcer disease, and diabetes mellitus.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with Dexamethasone (the active ingredient in Дексапос) are primarily categorized by their effect on drug concentrations and potential for additive risk. This information is strictly based on official regulatory labeling.


Documented Interaction Patterns

Interaction Type Interacting Agent Examples Official Regulatory Description
Metabolic (Exposure) Phenytoin, Rifampin (CYP3A4 Inducers) Increase Dexamethasone clearance, resulting in reduced plasma levels

. | | | Ketoconazole (CYP3A4 Inhibitor) | Inhibits Dexamethasone metabolism, resulting in increased plasma concentrations and effects. | | Pharmacodynamic Risk | NSAIDs, Alcohol | Additive risk of gastrointestinal ulcers and bleeding. | | | Potassium-Depleting Agents | Additive hypokalemic effect (increased potassium loss). | | Antagonism | Antidiabetic Medications | Dexamethasone's inherent hyperglycemic action antagonizes the blood-sugar-lowering effect of these agents. |


Interaction-Related Restrictions

Systemic Dexamethasone is formally contraindicated for co-administration with live attenuated vaccines when administered at immunosuppressive doses. This restriction reflects the potential for diminished serum antibody response. Use is also contraindicated in the presence of active systemic fungal infections due to the risk of exacerbation.

Oral Contraceptives containing estrogens are documented to decrease the clearance of Dexamethasone, which may increase its overall effects. Additionally, a high-fat meal may reduce the peak concentration of oral Dexamethasone by a small percentage, as noted in pharmacokinetic data.

Mechanism of Action

How Дексапос Works

Дексапос (dexamethasone sodium phosphate) is a water-soluble prodrug that is rapidly converted to its active metabolite, dexamethasone, a synthetic glucocorticoid. The mechanism begins with dexamethasone passing the cell membrane to bind with the cytoplasmic glucocorticoid receptor (GR). This ligand-receptor complex then translocates into the cell nucleus.

Once in the nucleus, the complex acts as a transcription factor, binding to specific DNA sequences known as glucocorticoid response elements (GREs). This genomic action modulates the transcription of various target genes. Specifically, it promotes the synthesis of anti-inflammatory proteins, such as annexin-1 (lipocortin).

Annexin-1 inhibits the enzyme phospholipase A2 (PLA2), thereby blocking the release of arachidonic acid from membrane phospholipids. The suppression of arachidonic acid formation consequently prevents the subsequent synthesis of pro-inflammatory eicosanoids, including prostaglandins and leukotrienes. Concurrently, the GR complex directly suppresses the gene expression of pro-inflammatory mediators such as cytokines (IL-1, IL-6, TNF-alpha) and enzymes like cyclooxygenase-2 (COX-2).

This cascade of actions results in the modulation of capillary permeability, stabilization of lysosomal membranes, and inhibition of leukocyte migration (chemotaxis) at the molecular and tissue level.

Dosage and Administration Information

Administration Guidelines

Administration of Dexamethasone (the active component in Дексапос) is based on the route, frequency, and duration of use. The medication is indicated for systemic administration via oral forms (tablets, elixir) and parenteral routes, specifically intravenous (IV) and intramuscular (IM) injection. Localized use is also applied via specialized injections, such as intra-articular routes, and through ophthalmic (topical eye) formulations.

Dosing and Scheduling Principles

Starting dosages are highly variable, typically ranging from 0.75 mg to 9 mg daily for general systemic use. However, specific regimens may require high-dose levels of up to 40 mg for certain conditions, or a fixed 6 mg daily dose for specific acute presentations. The prescribed dose is generally intended to be reduced toward a minimal maintenance level following an initial response.

When administered once daily, the drug should be taken in the morning to align with the body’s natural cortisol rhythm, and oral forms are generally taken with food to minimize irritation. Oral concentrate solutions must be fully diluted and consumed immediately.

Procedural Requirements

For any course of therapy lasting longer than a few weeks, the dose must be gradually reduced (tapered) before treatment is stopped. Abrupt discontinuation of prolonged systemic use is not recommended. Pediatric dosing is determined by body weight or body surface area, establishing different criteria than for adults.

Recent Clinical Evidence

Research Evidence for Acute Inflammatory and Pain States

Research exploring Dexamethasone for conditions like acute asthma exacerbations and gout relies on systematic reviews and Randomized Controlled Trials (RCTs). These studies examined short-term symptom changes, focusing on outcomes like the need for hospital care and changes in pain scores. Findings describe patterns observed over defined time intervals, typically 30 days or less. However, comparative evidence is lacking, as few published placebo-controlled trials exist for oral regimens in this area. Follow-up durations were limited, meaning long-term effects are not fully established.


Research in Supportive Oncology Settings

Dexamethasone research describes its use as a required component of complex, multi-drug combination regimens for specific oncological conditions, such as Multiple Myeloma. Research explored long-term outcomes, including overall survival and patient response rates, monitoring patients for months or years. It is not fully established what the precise contribution of Dexamethasone alone is, as its effects are not isolated from the combination therapy in these major clinical trials.


Studies in Acute Allergic Conditions and Evidence Gaps

For severe allergic reactions, the data are still emerging, and evidence is often derived from retrospective studies. Outcomes describing the occurrence of a second reaction and duration of hospital stay were examined. Research has also looked at special groups, such as pediatric patients (children), in asthma trials. Overall, evidence quality varies across studies, and data for certain groups and specific dosing regimens remain insufficient. The evidence base highlights what is known and what is still uncertain across the research landscape.

Key Studies & References Dexamethasone Drug Information (MedlinePlus/DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Дексапос (FAQ)


Q: How quickly should I expect relief from inflammation after starting Дексапос?

A: According to official information, symptoms of inflammation in the eye generally begin to improve quickly. Patients often report starting to feel relief within a few days of beginning treatment with these steroid eye drops. If you do not notice an improvement within the period specified by your doctor, you may need to consult them again.


Q: Are there different forms of Дексапос available (e.g., drops vs. ointment)?

A: The active ingredient in Дексапос, Dexamethasone, is officially available in various topical ophthalmic preparations. The medication is available in both ophthalmic suspension (drops) and ophthalmic ointment forms, based on the prescribed regimen.


Q: What happens if I stop using Дексапос too soon?

A: If the drops are used for longer than a few weeks, regulatory guidance suggests the dose should be gradually reduced before stopping completely. If treatment is stopped suddenly, especially after prolonged use, there is a risk that the underlying inflammatory eye condition may quickly return or worsen. It is important to use the medication for the entire duration specified in the prescribed regimen.


Q: Is Дексапос used for conditions other than eye inflammation?

A: The ophthalmic product is specifically for treating inflammation and related conditions in the eye. However, the active ingredient, Dexamethasone, is a versatile steroid that is approved in its systemic (oral or injection) forms for a wide range of other conditions, including certain types of allergies, endocrine issues, and other inflammatory disorders throughout the body.


Q: Will Дексапос affect my ability to drive or operate machinery?

A: Regulatory product information advises caution. Because the eye drops can cause temporary effects like blurred or cloudy vision immediately following application, it is advised that you wait until your vision has completely cleared before driving or operating machinery. Avoid these activities if vision is blurred.


Q: Does Дексапос help with redness caused by allergies?

A: Official information indicates that this medicine, being a potent corticosteroid, is used to treat eye swelling, redness, and itching. These symptoms may be caused by various factors, including certain severe allergies and other inflammatory conditions.


Q: Does sun exposure or bright light affect treatment with Дексапос?

A: Regulatory documents list increased sensitivity to light (photophobia) as a reported side effect of the eye drops. However, there is no indication in the official labeling that normal sun exposure or bright light affects the actual anti-inflammatory effect or efficacy of the medicine itself.


Q: If I miss an application, should I apply it as soon as I remember or wait for the next scheduled time?

A: According to typical patient instructions, if a dose of the eye drops is missed, you should apply it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose entirely and continue with your regular schedule. Do not attempt to apply extra drops to make up for a missed application.


Q: Can prolonged use of Дексапос lead to thinning of the eye tissues?

A: Regulatory documents include a warning that in eye diseases causing thinning of the cornea or sclera (the outer layers of the eye), the use of topical corticosteroids has been associated with an increased risk of perforation. Close monitoring by a healthcare provider is recommended during the course of treatment to manage this potential risk.


Q: Is it common for people to gain weight while using steroid eye drops like Дексапос?

A: Weight gain is a known side effect primarily associated with systemic use of the active ingredient (oral tablets or injections). While the eye drops are intended for local action, the amount absorbed into the body is generally minimal. Patients should be aware that systemic side effects correlate with the amount of medication absorbed.


Q: How is Дексапос different from other dexamethasone products (e.g., oral tablets)?

A: The key difference lies in the route of administration and the intended effect. Дексапос eye drops are formulated for localized action, treating inflammation directly in the eye while minimizing whole-body exposure. Oral tablets, by contrast, are intended for systemic (whole-body) effects and are used for various non-eye-related conditions.


Q: Are there any non-eye related side effects to watch out for, even with a topical application?

A: Although the drops primarily treat the eye, some of the active ingredient can be absorbed into the body. Reported systemic side effects, which are not focused on the eye, can include headache, dizziness, or stomach upset, though these are typically less common than local eye effects.


Q: Is it safe to get a flu shot or other vaccinations while using Дексапос?

A: Systemic use of dexamethasone at immunosuppressive doses is specifically contraindicated with live attenuated vaccines. Any use alongside specific vaccines should be discussed with a healthcare provider.


Q: Why is shaking the bottle necessary for some forms of Дексапос drops?

A: Shaking is specifically required for suspension formulations of the eye drops. This procedure ensures that the medicine is evenly mixed throughout the liquid. This mixing is essential for delivering the correct and consistent amount of the active ingredient with every single drop.


Q: Does Дексапос suppress the immune response in the eye?

A: Official drug information confirms that the active ingredient is a corticosteroid recognized for its dual actions: reducing inflammation and suppressing the immune response. This mechanism is central to its therapeutic effect in treating severe inflammation in the eye.


Q: Can Дексапос be used in combination with artificial tears or other lubricant drops?

A: When using the eye drops alongside any other topical eye products, regulatory guidance suggests a brief waiting period. A pause of approximately five minutes between applying different types of drops is generally recommended to prevent the second application from washing out the medication from the first.


Q: Does Дексапос interact with over-the-counter pain relievers?

A: The systemic form of the active ingredient has known interactions, particularly with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which can increase the risk of gastrointestinal issues. Although absorption from eye drops is usually low, the use of any over-the-counter pain relievers should be discussed with a healthcare provider.


Q: What are the signs of increased eye pressure while using Дексапос?

A: Prolonged use of steroid eye drops can increase the risk of glaucoma, which involves elevated pressure inside the eye. Signs that may indicate high eye pressure include sudden, severe eye pain, a persistent headache, or seeing bright, colorful circles or halos around lights.


Q: What kind of research exists about the effectiveness of Дексапос for post-operative recovery?

A: Research and clinical use have specifically addressed the active ingredient's role in the recovery process. Specialized forms of the medication, such as ophthalmic inserts, are used to manage eye pain and swelling that follow various types of eye surgery.


Q: Will using Дексапос mask a more serious underlying eye infection?

A: Official warnings state that corticosteroids may mask or enhance an existing eye infection, and they are contraindicated (should not be used) in the presence of an active, untreated infection. Due to this masking effect, regular monitoring by a healthcare provider is generally part of the treatment protocol.


Q: What is the difference between Дексапос and other common anti-inflammatory eye drops?

A: Дексапос contains Dexamethasone, which is classified as a potent synthetic Glucocorticoid (a type of steroid). This distinguishes it from other non-steroidal anti-inflammatory eye drops. The steroid classification means it is designed for strong anti-inflammatory and immunosuppressive action.


Q: Is it safe to use Дексапос if I wear contact lenses?

A: If you wear soft contact lenses, official instructions state that they must be removed before you apply the drops. The official safety precautions state that you should wait at least 15 minutes after administering the drops before reinserting your lenses, as the preservative may be absorbed by the lens material.

How should Дексапос be stored and disposed of?

Storage and Disposal Requirements

The storage and disposal instructions for Dexamethasone ophthalmic preparations (as found in Дексапос) are strictly defined by regulatory labeling to ensure product stability and safety.

Storage Component Official Labeled Requirement
Temperature Typically store at Controlled Room Temperature (15 C to 30 C). Certain specialized formulations may require refrigeration but are prohibited from freezing.
Protection The product must be stored out of direct light and out of the reach of children.
Handling & Stability The dropper tip must not be touched to prevent contamination. The product must be discarded within 28 to 30 days after first opening the container.
Disposal Any unused or expired medicine must be disposed of in accordance with local pharmaceutical waste requirements.

These conditions define the mandatory environment required to maintain the medication's integrity.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Дексапос found in:

A-Z Index: